Werner syndrome is an autosomal recessive disorder characterized by genomic
instability and by the premature onset of a number of age-related diseases
, including malignancy. To assess a potential collaboration between p21 or
p53 cell cycle regulators and Wrn proteins, Wrn mutant mice were created an
d mated with p21 or p53 null mice to generate double mutants. The p21 null/
Wrn mutant mice did not show an acceleration of tumorigenesis during the fi
rst year of life, suggesting that the p53-dependent G(1)-S cell cycle check
point (which operates via p21) is not involved in Wrn-abetted tumor suppres
sion. In contrast, the p53 null/Wrn mutant mice were particularly remarkabl
e with respect to the rapidity with which they developed tumors. These mice
were also distinguished by the variety of tumors they developed compared t
o those that developed in p53 null mice. Such data suggest a genetic intera
ction between p53 and Wrn in which loss of Wrn provokes a more variable p53
response unrelated to its role in the G(1)-S cell cycle checkpoint.